Biosimilar Launch Notification: Solicitor General Backs Pre-FDA Approval Notice

Government urges Supreme Court to take up Sandoz’s Zarxio petition challenging Federal Circuit’s interpretation of the biosimilars statue; says it should also review Amgen’s challenge of ruling on patent dance.